alkenes has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Happ, AM; Jakubowski, JA; Layman, N; Mais, DE; Takeuchi, K; Utterback, BG; Wyss, VL | 1 |
1 other study(ies) available for alkenes and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition--I. Synthesis, structure-activity relationship, and evaluation of substituted omega-phenyl-omega-(3-pyridyl)alkenoic acids.
Topics: 6-Ketoprostaglandin F1 alpha; Alkenes; Animals; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Structure-Activity Relationship; Thromboxane B2; Thromboxane-A Synthase | 1994 |